...
首页> 外文期刊>Science Advances >A biomimetic platelet based on assembling peptides initiates artificial coagulation
【24h】

A biomimetic platelet based on assembling peptides initiates artificial coagulation

机译:一种基于组装肽的仿生血小板引发了人工凝血

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Platelets play a critical role in the regulation of coagulation, one of the essential processes in life, attracting great attention. However, mimicking platelets for in vivo artificial coagulation is still a great challenge due to the complexity of the process. Here, we design platelet-like nanoparticles (pNPs) based on self-assembled peptides that initiate coagulation and form clots in blood vessels. The pNPs first bind specifically to a membrane glycoprotein (i.e., CD105) overexpressed on angiogenetic endothelial cells in the tumor site and simultaneously transform into activated platelet-like nanofibers (apNFs) through ligand-receptor interactions. Next, the apNFs expose more binding sites and recruit and activate additional pNPs, forming artificial clots in both phantom and animal models. The pNPs are proven to be safe in mice without systemic coagulation. The self-assembling peptides mimic platelets and achieve artificial coagulation in vivo, thus providing a promising therapeutic strategy for tumors.
机译:血小板在凝血的调节中起着关键作用,生活中的重要过程之一,吸引了极大的关注。然而,由于该过程的复杂性,模仿体内人工凝血的血小板仍然是一个巨大的挑战。这里,我们基于自组装肽设计血小板纳米颗粒(PNP),其引发血管中的凝固和形成凝块。 PNPS首先将特异性结合到肿瘤部位中的血管生成内皮细胞上过表达的膜糖蛋白(即CD105),并通过配体 - 受体相互作用同时转化为活性的血小板状纳米纤维(APNF)。接下来,APNFS暴露更多的结合位点并募集并激活额外的PNP,在幻像和动物模型中形成人工凝块。已证明PNPS在没有全身凝固的情况下是安全的。自组装肽模拟血小板并在体内实现人工凝结,从而为肿瘤提供有希望的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号